Karyopharm Therapeutics (KPTI) Assets (2012 - 2026)
Karyopharm Therapeutics' Assets came in at $111.32 million for Q2 2026, up 6.1% from $104.88 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Assets (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics' Assets was $108.42 million, down 34.1% from FY2024.
- Assets has declined in each of the last three years, with a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
- Going back by year, Assets was $164.42 million in FY2024 (-31.6%), $240.44 million in FY2023 (-32.9%), $358.17 million in FY2022 (+17.3%) and $305.31 million in FY2021 (-2.5%).
- The Q2 2026 figure represents the highest quarterly Assets since Q1 2025.
- Year-over-year, Assets increased in 1 of the last seven quarters, with an average decline of 32.4%.
- The fastest year-over-year change in Assets over five years came in Q4 2022 (growth of 17.3%), and the weakest in Q2 2025 (a decline of 51.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Karyopharm Therapeutics | 14.83 Mn | -211.60 Mn | 32.35 Mn | 111.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.32 Mn |
| Dec 31, 2025 | 108.42 Mn |
| Sep 30, 2025 | 96.23 Mn |
| Jun 30, 2025 | 104.88 Mn |
| Mar 31, 2025 | 127.71 Mn |
| Dec 31, 2024 | 164.42 Mn |
| Sep 30, 2024 | 189.48 Mn |
| Jun 30, 2024 | 213.98 Mn |
| Mar 31, 2024 | 204.46 Mn |
| Dec 31, 2023 | 240.44 Mn |
| Sep 30, 2023 | 269.96 Mn |
| Jun 30, 2023 | 297.83 Mn |
| Mar 31, 2023 | 325.80 Mn |
| Dec 31, 2022 | 358.17 Mn |
| Sep 30, 2022 | 231.24 Mn |
| Jun 30, 2022 | 256.48 Mn |
| Mar 31, 2022 | 294.03 Mn |
| Dec 31, 2021 | 305.31 Mn |
| Sep 30, 2021 | 254.09 Mn |
| Jun 30, 2021 | 286.57 Mn |
API Access
Karyopharm Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();